Circadian clock characteristics are altered in human thyroid malignant nodules

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 11, 2013, Pages 4446-4456

  Mannic, Tiphaine ^a   Meyer, Patrick ^a   Triponez, Frederic ^a   Pusztaszeri, Marc ^a   Le Martelot, Gwendal ^b   Mariani, Olivia ^c   Schmitter, Daniel ^c   Sage, Daniel ^c   Philippe, Jacques ^a   Dibner, Charna ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CRYPTOCHROME 2; PER2 PROTEIN; PROTEIN BMAL1;

ADULT; AGED; ARTICLE; BMAL1 GENE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CRY2 GENE; DOWN REGULATION; FEMALE; FOLLICULAR THYROID CARCINOMA; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OSCILLATION; PER2 GENE; PRIORITY JOURNAL; THYROID CANCER; THYROID CARCINOMA; THYROID CELL; THYROID NODULE; UPREGULATION;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHRONOBIOLOGY DISORDERS; CIRCADIAN RHYTHM; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; PRIMARY CELL CULTURE; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY; TRANSCRIPTOME; YOUNG ADULT;

EID: 84887502407     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2568     Document Type: Article

References (37)

1. Gharib H. Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clin Proc. 1994;69: 44-49.
2. Ibrahimpasic T, Ghossein R, Carlson DL, et al. Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986-2009 Memorial Sloan-Kettering cancer center experience. Thyroid. 2013;23(8): 997-1002.
3. Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2009;19: 1159-1165.
4. Walsh PS, Wilde JI, Tom EY, et al. Analytical performance verification of a molecular diagnostic for cytology-indeterminate thyroid nodules. J Clin Endocrinol Metab. 2012;97:E2297-E2306.
5. Sigstad E, Paus E, Bjoro T, et al. The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors. Mod Pathol. 2012;25: 537-547.
6. Dibner C, Schibler U, Albrecht U. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol. 2010;72: 517-549.
7. Nagoshi E, Saini C, Bauer C, Laroche T, Naef F, Schibler U. Circadian gene expression in individual fibroblasts: cell-autonomous and self-sustained oscillators pass time to daughter cells. Cell. 2004; 119: 693-705.
8. Kowalska E, Ripperger JA, Hoegger DC, et al. NONO couples the circadian clock to the cell cycle. Proc Natl Acad Sci USA. 2013;110: 1592-1599.
9. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science. 2003;302: 255-259.
10. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell. 2002;111: 41-50.
11. Sancar A, Lindsey-Boltz LA, Kang TH, Reardon JT, Lee JH, Ozturk N. Circadian clock control of the cellular response toDNAdamage. FEBS Lett. 2010;584(12): 2618-2625.
12. HuaH,WangY,WanC, et al. Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci. 2006;97: 589-596.
13. Levi F, Okyar A, Dulong S, Innominato PF, Clairambault J. Circadian timing in cancer treatments. Annu Rev Pharmacol Toxicol. 2010;50: 377-421.
14. Haus E. Chronobiology in the endocrine system. Adv Drug Deliv Rev. 2007;59: 985-1014.
15. DeLellis R, Lloyd R, Heitz P, Eng C, The International Agency for Research on Cancer. In: Lloyd R, Heitz P, Eng C, eds. Pathology and Genetics of Tumours of Endocrine Organs (International Agency for Research on Cancer-World Health Organization Classification of Tumours). International Agency for Research on Cancer; 2004.
16. Dibner C, Sage D, Unser M, Bauer C, et al. Circadian gene expression is resilient to large fluctuations in overall transcription rates. EMBO J. 2009;28: 123-134.
17. Pulimeno P, Mannic T, Sage D, et al. Autonomous and self-sustained circadian oscillators displayed in human islet cells. Diabetologia. 2013;56: 497-507.
18. Liu AC, Tran HG, Zhang EE, Priest AA, Welsh DK, Kay SA. Redundant function of REV-ERBα and β and non-essential role for Bmal1 cycling in transcriptional regulation of intracellular circadian rhythms. PLoS Genet. 2008;4(2):e1000023.
19. MarlerMR,Gehrman P, Martin JL, Ancoli-Israel S. The sigmoidally transformed cosine curve: a mathematical model for circadian rhythms with symmetric non-sinusoidal shapes. Stat Med. 2006;25: 3893-3904.
20. Wasenius VM, Hemmer S, Kettunen E, Knuutila S, Franssila K, Joensuu H. Hepatocyte growth factor receptor, matrix metalloproteinase- 11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study. Clin Cancer Res. 2003;9: 68-75.
21. Hawthorn L, Stein L, Varma R, Wiseman S, Loree T, Tan D. TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma. Head Neck. 2004;26: 1069-1083.
22. Balsalobre A, Brown SA, Marcacci L, et al. Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science. 2000; 289: 2344-2347.
23. Brown SA, Fleury-Olela F, Nagoshi E, et al. The period length of fibroblast circadian gene expression varies widely among human individuals. PLoS Biol. 2005;3:e338.
24. Yoo SH, Yamazaki S, Lowrey PL, et al. PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc Natl Acad Sci USA. 2004;101: 5339-5346.
25. Schmidt EE, Schibler U. High accumulation of components of the RNA polymerase II transcription machinery in rodent spermatids. Development. 1995;121: 2373-2383.
26. Kalsbeek A, van der Spek R, Lei J, Endert E, Buijs RM, Fliers E. Circadian rhythms in the hypothalamo-pituitary-adrenal (HPA) axis. Mol Cell Endocrinol. 2012;349: 20-29.
27. Sviridonova MA, Fadeyev VV, Sych YP, Melnichenko GA. Clinical significance of TSH circadian variability in patients with hypothyroidism. Endocr Res. 2013;38: 24-31.
28. Jazdzewski K, Boguslawska J, Jendrzejewski J, et al. Thyroid hormone receptor β (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC). J Clin Endocrinol Metab. 2011;96:E546-E553.
29. Hughes ME, Hogenesch JB, Kornacker K. JTK-CYCLE: an efficient nonparametric algorithm for detecting rhythmic components in genome- scale data sets. J Biol Rhythms. 2010;25: 372-380.
30. Straume M. DNA microarray time series analysis: automated statistical assessment of circadian rhythms in gene expression patterning. Methods Enzymol. 2004;383: 149-166.
31. Yang R, Su Z. Analyzing circadian expression data by harmonic regression based on autoregressive spectral estimation. Bioinformatics. 2010;26:i168-i174.
32. Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis. 2005;26: 1241-1246.
33. Gaddameedhi S, Selby CP, Kaufmann WK, Smart RC, Sancar A. Control of skin cancer by the circadian rhythm. Proc Natl Acad Sci USA. 2011;108: 18790-18795.
34. Hsu CM, Lin SF, Lu CT, Lin PM, Yang MY. Altered expression of circadian clock genes in head and neck squamous cell carcinoma. Tumour Biol. 2012;33: 149-155.
35. Relles D, Sendecki J, Chipitsyna G, Hyslop T, Yeo CJ, Arafat HA. Circadian gene expression and clinicopathologic correlates in pancreatic cancer. J Gastrointest Surg. 2013;17: 443-450.
36. Yang MY, Yang WC, Lin PM, et al. Altered expression of circadian clock genes in human chronic myeloid leukemia. J Biol Rhythms. 2011;26: 136-148.
37. Kondratov RV, Kondratova AA, Gorbacheva VY, Vykhovanets OV, Antoch MP. Early aging and age-related pathologies in mice deficient in BMAL1, the core component of the circadian clock. Genes Dev. 2006;20: 1868-1873.